Clarus permits Greenhouse and Kanders to increase stakes to 15% and 26.7% under poison pill waiver

Clarus Corp

Greenhouse (current ~11.9% owner) approved to acquire up to 15.0% of CLAR common stock within 12 months.
Executive Chairman Warren Kanders (current ~16.7%) approved to acquire up to 26.7% within 12 months.
Waivers terminate if either party's ownership falls below 9.9%; new board approval required to exceed that threshold.
Approvals are conditioned on not exceeding the stated caps and apply to the 2008 Rights Agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.